Medtronic - 52 Year Stock Price History | MDT
- The all-time high Medtronic stock closing price was 119.33 on September 08, 2021.
- The Medtronic 52-week high stock price is 96.25, which is 8.5% above the current share price.
- The Medtronic 52-week low stock price is 75.96, which is 14.4% below the current share price.
- The average Medtronic stock price for the last 52 weeks is 86.32.
Medtronic Historical Annual Stock Price Data | ||||||
---|---|---|---|---|---|---|
Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
2025 | 86.0898 | 78.9332 | 92.9842 | 78.5593 | 88.7500 | 12.92% |
2024 | 81.4757 | 78.8196 | 90.0111 | 74.3722 | 78.5987 | 0.28% |
2023 | 76.3543 | 72.0280 | 84.8247 | 65.5116 | 78.3819 | 9.58% |
2022 | 85.1379 | 94.7251 | 101.5680 | 69.4498 | 71.5310 | -22.55% |
2021 | 107.5284 | 101.3990 | 119.3290 | 88.2970 | 92.3592 | -9.79% |
2020 | 88.9989 | 97.8061 | 103.5600 | 62.2558 | 102.3780 | 5.70% |
2019 | 83.4104 | 73.5218 | 97.3249 | 68.9476 | 96.8585 | 27.34% |
2018 | 72.6263 | 67.2304 | 82.7278 | 62.9636 | 76.0639 | 15.18% |
2017 | 65.6628 | 56.4832 | 71.8651 | 56.4832 | 66.0364 | 15.90% |
2016 | 63.6004 | 59.3542 | 70.3565 | 56.8866 | 56.9791 | -5.44% |
2015 | 58.2548 | 55.2251 | 61.2425 | 50.2911 | 60.2550 | 8.62% |
2014 | 47.9357 | 43.1741 | 57.8199 | 40.4286 | 55.4710 | 28.15% |
2013 | 38.3324 | 30.9309 | 44.1643 | 30.9309 | 43.2872 | 42.88% |
2012 | 28.9753 | 27.6969 | 32.7902 | 26.0147 | 30.2957 | 10.64% |
2011 | 26.2122 | 26.0973 | 30.4951 | 21.6049 | 27.3819 | 5.83% |
2010 | 26.8666 | 29.9582 | 31.5561 | 21.6276 | 25.8741 | -13.79% |
2009 | 23.7307 | 21.8513 | 30.6406 | 16.3366 | 30.0128 | 42.55% |
2008 | 31.0664 | 32.6354 | 37.5162 | 19.0918 | 21.0539 | -36.32% |
2007 | 33.9646 | 34.3397 | 37.9694 | 29.7592 | 33.0607 | -5.22% |
2006 | 32.8683 | 37.4013 | 38.5579 | 27.6197 | 34.8805 | -6.29% |
2005 | 34.7312 | 31.7360 | 37.8151 | 31.3536 | 37.2203 | 16.71% |
2004 | 31.6946 | 30.9339 | 34.2079 | 29.6892 | 31.8901 | 2.69% |
2003 | 30.1046 | 29.6451 | 33.5337 | 27.3715 | 31.0553 | 7.24% |
2002 | 28.1068 | 31.5773 | 31.5773 | 21.3688 | 28.9592 | -10.36% |
2001 | 29.2013 | 37.3627 | 37.3627 | 24.5638 | 32.3048 | -14.79% |
2000 | 32.1603 | 21.4241 | 38.3046 | 21.4241 | 37.9122 | 66.34% |
1999 | 22.7457 | 22.7583 | 27.4747 | 19.5430 | 22.7925 | -1.49% |
1998 | 18.0940 | 15.5269 | 23.8875 | 14.1662 | 23.1379 | 42.10% |
1997 | 12.6497 | 10.3923 | 16.2829 | 9.0165 | 16.2829 | 55.24% |
1996 | 8.8689 | 7.9763 | 10.6815 | 7.2376 | 10.4887 | 22.38% |
1995 | 6.4098 | 4.0948 | 9.1843 | 4.0662 | 8.5707 | 101.78% |
1994 | 3.3858 | 3.1228 | 4.2475 | 2.6746 | 4.2475 | 36.92% |
1993 | 2.7038 | 3.5541 | 3.5541 | 2.0013 | 3.1021 | -13.05% |
1992 | 3.1405 | 3.4622 | 3.8765 | 2.3941 | 3.5675 | 1.95% |
1991 | 2.3209 | 1.5531 | 3.4994 | 1.4668 | 3.4994 | 119.76% |
1990 | 1.3836 | 1.1966 | 1.6893 | 1.0899 | 1.5924 | 32.82% |
1989 | 0.9535 | 0.7016 | 1.2765 | 0.7016 | 1.1989 | 71.44% |
1988 | 0.7366 | 0.8514 | 0.8870 | 0.6237 | 0.6993 | -15.99% |
1987 | 0.8006 | 0.6812 | 0.9624 | 0.5868 | 0.8324 | 22.79% |
1986 | 0.6271 | 0.3764 | 0.8003 | 0.3764 | 0.6779 | 79.05% |
1985 | 0.2950 | 0.2292 | 0.3829 | 0.2180 | 0.3786 | 65.18% |
1984 | 0.2536 | 0.3565 | 0.3621 | 0.2128 | 0.2292 | -33.37% |
1983 | 0.4029 | 0.4405 | 0.4875 | 0.3357 | 0.3440 | -21.55% |
1982 | 0.3415 | 0.3132 | 0.4579 | 0.2749 | 0.4385 | 41.86% |
1981 | 0.2937 | 0.3342 | 0.3463 | 0.2477 | 0.3091 | -6.67% |
1980 | 0.2992 | 0.2628 | 0.4309 | 0.2225 | 0.3312 | 19.18% |
1979 | 0.1801 | 0.1269 | 0.2779 | 0.1233 | 0.2779 | 116.60% |
1978 | 0.1060 | 0.0760 | 0.1611 | 0.0685 | 0.1283 | 67.71% |
1977 | 0.0965 | 0.0936 | 0.1148 | 0.0685 | 0.0765 | -15.56% |
1976 | 0.1087 | 0.1047 | 0.1440 | 0.0795 | 0.0906 | -13.47% |
1975 | 0.1388 | 0.1017 | 0.1762 | 0.0977 | 0.1047 | 7.16% |
1974 | 0.1440 | 0.2004 | 0.2135 | 0.0765 | 0.0977 | -50.48% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $111.799B | $33.537B |
Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $236.635B | 28.45 |
Boston Scientific (BSX) | United States | $158.907B | 39.78 |
Stryker (SYK) | United States | $151.008B | 31.58 |
EssilorLuxottica (ESLOY) | France | $127.124B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $51.541B | 0.00 |
Haleon (HLN) | United Kingdom | $46.605B | 26.59 |
ResMed (RMD) | United States | $37.830B | 28.41 |
GE HealthCare Technologies (GEHC) | United States | $33.916B | 16.10 |
Agilent Technologies (A) | United States | $33.522B | 21.85 |
Terumo (TRUMY) | Japan | $27.168B | 35.29 |
Koninklijke Philips (PHG) | Netherlands | $23.091B | 16.20 |
Insulet (PODD) | United States | $22.110B | 86.79 |
Zimmer Biomet Holdings (ZBH) | United States | $18.046B | 11.59 |
Baxter (BAX) | United States | $15.539B | 11.60 |
Smith & Nephew SNATS (SNN) | United Kingdom | $13.415B | 0.00 |
Demant (WILYY) | Denmark | $9.110B | 0.00 |
Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $6.567B | 22.85 |
Lantheus Holdings (LNTH) | United States | $5.664B | 14.29 |
Prestige Consumer Healthcare (PBH) | United States | $3.946B | 17.63 |
Perrigo (PRGO) | Ireland | $3.673B | 9.31 |
Haemonetics (HAE) | United States | $3.584B | 16.33 |
Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
Envista Holdings (NVST) | United States | $3.312B | 27.52 |
ICU Medical (ICUI) | United States | $3.252B | 23.98 |
QuidelOrtho (QDEL) | United States | $1.949B | 13.40 |
LeMaitre Vascular (LMAT) | United States | $1.876B | 41.94 |
AtriCure (ATRC) | United States | $1.622B | 0.00 |
Acuren (TIC) | United States | $1.341B | 0.00 |
AdaptHealth (AHCO) | United States | $1.273B | 12.92 |
Green Thumb Industries (GTBIF) | United States | $1.167B | 26.24 |
Neogen (NEOG) | United States | $1.037B | 13.28 |
Phibro Animal Health (PAHC) | United States | $1.035B | 13.23 |
BioLife Solutions (BLFS) | United States | $1.023B | 0.00 |
InMode (INMD) | Israel | $0.913B | 9.20 |
Kestra Medical Technologies (KMTS) | United States | $0.851B | 0.00 |
Owens & Minor (OMI) | United States | $0.703B | 5.83 |
CeriBell (CBLL) | United States | $0.677B | 0.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $0.614B | 0.00 |
Evolus (EOLS) | United States | $0.594B | 0.00 |
Curaleaf Holdings (CURLF) | Canada | $0.559B | 0.00 |
Valneva SE (VALN) | France | $0.482B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.454B | 0.00 |
Surmodics (SRDX) | United States | $0.425B | 0.00 |
Tilray Brands (TLRY) | Canada | $0.417B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.357B | 13.14 |
Quanterix (QTRX) | United States | $0.332B | 0.00 |
SNDL (SNDL) | Canada | $0.318B | 0.00 |
SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
Sanuwave Health (SNWV) | United States | $0.281B | 0.00 |
Viemed Healthcare (VMD) | United States | $0.273B | 23.03 |
Cerus (CERS) | United States | $0.270B | 0.00 |
ZimVie (ZIMV) | United States | $0.260B | 11.84 |
Sanara MedTech (SMTI) | United States | $0.252B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.252B | 0.00 |
Brainsway (BWAY) | Israel | $0.248B | 65.75 |
Aurora Cannabis (ACB) | Canada | $0.238B | 70.67 |
OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
Biote (BTMD) | United States | $0.220B | 6.18 |
TriSalus Life Sciences (TLSI) | United States | $0.206B | 0.00 |
High Tide (HITI) | Canada | $0.187B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.185B | 15.06 |
Organigram Global (OGI) | Canada | $0.181B | 0.00 |
Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
Omeros (OMER) | United States | $0.176B | 0.00 |
Exagen (XGN) | United States | $0.149B | 0.00 |
Vireo Growth (VREOF) | United States | $0.143B | 0.00 |
FitLife Brands (FTLF) | United States | $0.122B | 15.05 |
Jin Medical (ZJYL) | China | $0.102B | 0.00 |
Fonar (FONR) | United States | $0.093B | 11.97 |
Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
TerrAscend (TSNDF) | Canada | $0.085B | 0.00 |
Veru (VERU) | United States | $0.085B | 0.00 |
Apyx Medical (APYX) | United States | $0.085B | 0.00 |
Cytosorbents (CTSO) | United States | $0.080B | 0.00 |
Zynex (ZYXI) | United States | $0.078B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
MacroGenics (MGNX) | United States | $0.076B | 0.00 |
InterCure (INCR) | Israel | $0.067B | 0.00 |
Agape ATP (ATPC) | $0.066B | 0.00 | |
Jushi Holdings (JUSHF) | United States | $0.064B | 0.00 |
ImmuCell (ICCC) | United States | $0.063B | 0.00 |
Nephros (NEPH) | United States | $0.043B | 58.43 |
Modular Medical (MODD) | United States | $0.040B | 0.00 |
United-Guardian (UG) | United States | $0.037B | 12.70 |
Rockwell Medical (RMTI) | United States | $0.029B | 0.00 |
Safety Shot (SHOT) | United States | $0.025B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
INLIF (INLF) | $0.017B | 0.00 | |
Flora Growth (FLGC) | United States | $0.013B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
Senestech (SNES) | United States | $0.010B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
Akanda (AKAN) | Canada | $0.002B | 0.00 |
Sharps Technology (STSS) | United States | $0.000B | 0.00 |
InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |